Amylyx Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2020 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of unrecognized tax benefits.
Summary: Amylyx Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2020 to Q4 2023.
Amylyx Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $2.21M, a 118% increase year-over-year.

Unrecognized Tax Benefits, Quarterly (USD)

Unrecognized Tax Benefits, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$2.21M	+$1.2M	+118%	Dec 31, 2023	10-K	2024-02-22
Q4 2022	$1.01M	+$449K	+79.6%	Dec 31, 2022	10-K	2024-02-22
Q4 2021	$564K	+$215K	+61.6%	Dec 31, 2021	10-K	2024-02-22
Q4 2020	$349K			Dec 31, 2020	10-K	2024-02-22

* An asterisk sign (*) next to the value indicates that the value is likely invalid.